Fluorescence imaging to identify cancer-affected breast tissues introduced in AIIMS

In a first, a state-of-the-art fluorescence imaging technology for easy identification of cancer-affected tissues in breast has recently been introduced at the AIIMS here.

According to Dr SVS Deo, Head of the Department of Surgical Oncology at AIIMS, the technology will be a "game changer" in breast cancer surgery space as it precisely helps identify relevant tissue intraoperatively.

During breast cancer surgery, surgeons inject a safe and affordable indocyanine green (ICG) dye in patients. Using Fluorescence Imaging technology, surgeons can view blood flow in vessels, micro-vessels, tissue perfusion and critical anatomical structures intraoperatively.

"The relevant tissues light up in fluorescent green colour. The reliability and multiple applications of the imaging are a significant differentiation compared to currently used technologies like blue dye," he said.

"Due to lack of this critical information, earlier all lymph nodes including healthy ones would be removed completely causing significant collateral damage to patient. With Fluorescence Imaging technology we can now save healthy tissue and improve patient safety and outcomes," Dr Deo said.

The technology uses near-infrared fluorescence imaging during cancer surgery that allows real time, clinically significant and actionable information to improve quality of care, outcomes and safety of patients